Hält derzeit eine Position bei Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
General Counsel, Vice President of Corporate Development | Apellis Pharmaceuticals Inc | 1. Januar 2014 - |
Suchen
Datum der Benachrichtigung | Datum der Transaktion | K/V Art der Transaktion |
Anz. der Aktien Kurs Wert |
Anzahl der Aktien | Kurs | Gesamtwert | Details | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
781
-0.7%
67,7752.926 USD |
781 -0.7% | 67,77 | 52.926 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
906
-0.9%
64,1458.109 USD |
906 -0.9% | 64,14 | 58.109 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
4.184
-3.8%
65,00271.943 USD |
4.184 -3.8% | 65,00 | 271.943 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
4.240
-3.7%
66,81283.268 USD |
4.240 -3.7% | 66,81 | 283.268 USD | |
2023-12-20 | 2023-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
2.300
-2.5%
57,38131.980 USD |
2.300 -2.5% | 57,38 | 131.980 USD | |
2023-12-20 | 2023-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
1.605
-1.7%
57,0091.492 USD |
1.605 -1.7% | 57,00 | 91.492 USD | |
2023-07-06 | 2023-07-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
8.510
-9.0%
89,98765.730 USD |
8.510 -9.0% | 89,98 | 765.730 USD | |
2022-06-23 | 2022-06-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
10.000
-8.0%
44,51445.140 USD |
10.000 -8.0% | 44,51 | 445.140 USD | |
2022-04-27 | 2022-04-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-3.8%
50,00250.000 USD |
5.000 -3.8% | 50,00 | 250.000 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
300
-0.3%
48,5814.573 USD |
300 -0.3% | 48,58 | 14.573 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
5.097
-4.5%
47,86243.917 USD |
5.097 -4.5% | 47,86 | 243.917 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
5.174
-4.7%
47,72246.883 USD |
5.174 -4.7% | 47,72 | 246.883 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
200
-0.5%
55,9111.182 USD |
200 -0.5% | 55,91 | 11.182 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
900
-2.0%
55,0049.501 USD |
900 -2.0% | 55,00 | 49.501 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
900
-2.0%
53,8648.475 USD |
900 -2.0% | 53,86 | 48.475 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
1.163
-2.5%
52,7361.322 USD |
1.163 -2.5% | 52,73 | 61.322 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
2.526
-5.1%
51,32129.624 USD |
2.526 -5.1% | 51,32 | 129.624 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
2.709
-5.2%
50,61137.094 USD |
2.709 -5.2% | 50,61 | 137.094 USD | |
2020-12-15 | 2020-12-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Verkauf |
9.935
-18.6%
50,00496.750 USD |
9.935 -18.6% | 50,00 | 496.750 USD | |
2020-02-12 | 2020-02-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
5.000
-12.4%
44,50222.500 USD |
5.000 -12.4% | 44,50 | 222.500 USD | |
2020-01-28 | 2020-01-27 |
Apellis Pharmaceuticals Inc
(APLS)
|
GV Geplanter Verkauf |
3.000
-13.6%
40,47121.401 USD |
3.000 -13.6% | 40,47 | 121.401 USD |